You Searched For: Iron+(III)+phosphate+hydrate

Supplier: Merck

Description: Sodium dihydrogen phosphate, Suprapur® for trace analysis, Supelco®

MSDS

Supplier: SIGMA ALDRICH MICROSCOPY

Description: Naphthol AS-MX phosphate disodium salt,phosphatase substrate

Catalog Number: (BOSSBS-7818R-A750)

Supplier: Bioss

Description: Component of the cytosolic iron-sulfur (Fe/S) protein assembly machinery. Required for maturation of extramitochondrial Fe/S proteins. May bind and transfer a labile 4Fe-4S cluster to target apoproteins.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-7818R-CY5.5)

Supplier: Bioss

Description: Component of the cytosolic iron-sulfur (Fe/S) protein assembly machinery. Required for maturation of extramitochondrial Fe/S proteins. May bind and transfer a labile 4Fe-4S cluster to target apoproteins.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-7818R-A680)

Supplier: Bioss

Description: Component of the cytosolic iron-sulfur (Fe/S) protein assembly machinery. Required for maturation of extramitochondrial Fe/S proteins. May bind and transfer a labile 4Fe-4S cluster to target apoproteins.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-7818R-CY3)

Supplier: Bioss

Description: Component of the cytosolic iron-sulfur (Fe/S) protein assembly machinery. Required for maturation of extramitochondrial Fe/S proteins. May bind and transfer a labile 4Fe-4S cluster to target apoproteins.

UOM: 1 * 100 µl

Catalog Number: (W432-07)

Supplier: Avantor

Description: Tributyl phosphate, J.T.Baker®

UOM: 1 * 500 mL

Certificates

Catalog Number: (BOSSBS-7818R-A488)

Supplier: Bioss

Description: Component of the cytosolic iron-sulfur (Fe/S) protein assembly machinery. Required for maturation of extramitochondrial Fe/S proteins. May bind and transfer a labile 4Fe-4S cluster to target apoproteins.

UOM: 1 * 100 µl

Supplier: Merck

Description: di-Potassium hydrogen phosphate, anhydrous ≥99.99% (metals basis), Suprapur® for trace analysis, Supelco®

Catalog Number: (3864-40ML)

Supplier: SIGMA ALDRICH MICROSCOPY

Description: Naphthol AS-BI Phosphoric acid solution foruse in Sigma Acid Phosphatase Procedure No. 386.

UOM: 1 * 40 mL

Catalog Number: (USBI150950)

Supplier: US Biological

Description: Anti-SDHB Goat Polyclonal Antibody

UOM: 1 * 100 µG

Supplier: Merck

Description: Disodium hydrogen phosphate, anhydrous, EMSURE® (0.2 - 1 mm) for analysis, Supelco®

Catalog Number: (95924-100ML)

Supplier: Merck

Description: P as phosphate in water, 1000 mg/l, TraceCERT®, Supelco®, Application: Ion chromatography standards

UOM: 1 * 100 mL

Catalog Number: (USBI037099-PE)

Supplier: US Biological

Description: Anti-IREB2 Rabbit Polyclonal Antibody (PE (Phycoerythrin))

UOM: 1 * 200 µl

Catalog Number: (BOSSBS-12335R-FITC)

Supplier: Bioss

Description: The features of hemochromatosis include cirrhosis of the liver, diabetes, hypermelanotic pigmentation of the skin, and heart failure. Since hemochromatosis is a relatively easily treated disorder if diagnosed, this is a form of preventable cancer. The HFE protein, which is defective in hereditary hemo-chromatosis, normally is expressed in crypt enterocytes of the duodenum where it has a unique, predominantly intracellular localization. In placenta, the HFE protein co-localizes with and forms a stable association with the transferrin receptor (TfR), providing a link between the HFE protein and iron transport. Immunocytochemistry shows that the HFE protein and TfR both are expressed in the crypt enterocytes. Western blots show that, as is the case in human placenta, the HFE protein in crypt enterocytes is physically associated with the TfR and with β2-microglobulin. It is proposed that HFE has two mutually exclusive activities in cells: inhibition of uptake or inhibition of release of iron and that the balance between serum transferrin saturation and serum transferrin-receptor concentrations determines which of these functions predominates. The gene which encodes HFE maps to human chromosome 6p21.3.

UOM: 1 * 100 µl

Catalog Number: (BOSSBS-12335R-A555)

Supplier: Bioss

Description: The features of hemochromatosis include cirrhosis of the liver, diabetes, hypermelanotic pigmentation of the skin, and heart failure. Since hemochromatosis is a relatively easily treated disorder if diagnosed, this is a form of preventable cancer. The HFE protein, which is defective in hereditary hemo-chromatosis, normally is expressed in crypt enterocytes of the duodenum where it has a unique, predominantly intracellular localization. In placenta, the HFE protein co-localizes with and forms a stable association with the transferrin receptor (TfR), providing a link between the HFE protein and iron transport. Immunocytochemistry shows that the HFE protein and TfR both are expressed in the crypt enterocytes. Western blots show that, as is the case in human placenta, the HFE protein in crypt enterocytes is physically associated with the TfR and with β2-microglobulin. It is proposed that HFE has two mutually exclusive activities in cells: inhibition of uptake or inhibition of release of iron and that the balance between serum transferrin saturation and serum transferrin-receptor concentrations determines which of these functions predominates. The gene which encodes HFE maps to human chromosome 6p21.3.

UOM: 1 * 100 µl